Biolase inc.

Orbit Irrigation Products, Inc. commonly referred to as simply Orbit, produces irrigation products for residential and commercial home and garden use. Occasionally, you may need to reference one of Orbit’s product manuals for the proper use...

Biolase inc. Things To Know About Biolase inc.

BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company …Biolase Inc (NASDAQ:BIOL)’s Major holders. Investors are also buoyed by the number of investors in a company, with Biolase Inc having a total of N/A institutions that hold shares in the company. The top two institutional holders are Walleye Capital LLC with over 14205.0 shares worth more than $0.1 million.9/30/2023: ANSON FUNDS MANAGEMENT LP Bought 51.3 Thousand shares of BIOLASE Inc: 9/30/2023: BLACKROCK FUND ADVISORS Bought 23.8 Thousand shares of BIOLASE Inc: 9/30/2023: ZHANG FINANCIAL LLC ...

The new handpiece uses advanced, proprietary technology to deliver faster healing and quicker recovery for skin-resurfacing patients LAKE FOREST, Calif., Feb. 23, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the U.S. launch of the Waterlase Fractional Handpiece for doctors …Prior to joining BIOLASE, Brown was a co-founder of Kreativ, Inc., an international advanced dental equipment company, from 1995 until it was acquired in 1999 by Welch-Allyn, Inc., at which time he served as Director of New Product Development and Board Director for Welch-Allyn Kreativ, Inc. until 2002.BIOLASE Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. BIOLASE Inc’s trailing 12-month revenue is $49.7 million with a -50.6% profit margin. Year-over-year quarterly sales growth most recently was -9.2%. Analysts expect adjusted earnings to reach $-26.145 per share for the current fiscal year.

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.

Global Leader in Dental Lasers. BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes.Apr 28, 2022 · COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split of the Company's ... Nov 4, 2021 · IRVINE, Calif., Nov. 4, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has launched the Epic Hygiene Academy, bringing together leaders in the dental hygiene profession to provide improved continuing education and support the delivery of superior patient care through laser technology. BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 720380.Charts. Forms. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….

1997. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….

I joined BIOLASE in 2002 as the Director of Marketing before advancing to the VP, Sales and Marketing and VP, International positions. In these roles, I was instrumental in establishing BIOLASE ...

Nov 17, 2023 · BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…About BIOLASE, Inc. BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of ...Aug 11, 2022 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2022, and to answer questions. To access the live call, dial 1-877-545-0320 (U.S.) or +1 973-528-0002 (International) and provide the following code: 838343. BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 720380.BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems. With over 43,300 laser systems sold to date in over 80 countries around the world, BIOLASE lasers are designed to provide clinically superior, patient-friendly results compared to those achieved with ...

BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems. With over 43,300 laser systems sold to date in over 80 countries around the world, BIOLASE lasers are designed to provide clinically superior, patient-friendly results compared to those achieved with ... BIOLASE, Inc. (“BIOLASE” and, together with its consolidated subsidiaries, the “Company,” “we,” “our” or “us”) is a leading provider of advanced laser systems for the dental industry. We develop, manufacture, market, and sell laser systems that provide significant benefits for dental practitioners and their patients.Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsApr 28, 2022 · COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON APRIL 29, 2022. LAKE FOREST, Calif., April 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), today announced that it held its annual meeting of stockholders on April 28, 2022 where the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split of the Company's ... 700 µs. Tip Diameter. 200 – 1200 µm. The first Waterlase iPlus debuted in February 2012. Since then, the technology has been updated, refined and enhanced on numerous occasions to ensure the best experience for dentist and patient alike. Dimensions. 11 x 19 x 33 in (28 x 48 x 84cm) Weight. 75 lbs. (34 kg) 700 µs. Tip Diameter. 200 – 1200 µm. The first Waterlase iPlus debuted in February 2012. Since then, the technology has been updated, refined and enhanced on numerous occasions to ensure the best experience for dentist and patient alike. Dimensions. 11 x 19 x 33 in (28 x 48 x 84cm) Weight. 75 lbs. (34 kg) Prior to joining BIOLASE, Brown was a co-founder of Kreativ, Inc., an international advanced dental equipment company, from 1995 until it was acquired in 1999 by Welch-Allyn, Inc., at which time he served as Director of New Product Development and Board Director for Welch-Allyn Kreativ, Inc. until 2002.

Preparing a financial plan for your business is important if you plan to pursue business finance options such as loans, according to Inc. Business finance companies look at the short-term viability as well as the long-term potential of a bu...BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine.

Filter stock price historical data by date with the ability to view Opens, Highs, Lows, Closes, VWAPs, Volume % Change, Change, Trade Value and Trades. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to ...May 26, 2023 · LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a ... BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live call, dial 1-877-545-0523 (U.S.) or +1 973-528-0016 (International) and provide the following code: 180082.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2020, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the …biolase careers Join Us in Advancing Dentistry Search Open Positions BIOLASE Named 2022 TOP WORKPLACE BIOLASE was recognized as a Top Workplace in 2022 by both the Orange County Register and the Inland News Group. The award was based on feedback collected through an employee survey administered by Energage LLC in July and August 2022. […]BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the company has formed a community of periodontists through the development of the Waterlase Perio Academy (WPA). The goal of the WPA is to assist clinicians in providing periodontal and implant services with …

Biolase Mucocele Removal Protocol. Follow. from BIOLASE, Inc. 2 years ago — via Parallel Uploader. Recommended; Description; Comments.

LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable …

View and filter SEC Filings by group or type. Annual Reports Quarterly Reports View All. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….Nov 7, 2023 · Recent Event. Q3 2023 Financial Results Conference Call. Nov 9, 2023 • 1:30 pm PST. View Event View All Events. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally ... BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…9/30/2023: ANSON FUNDS MANAGEMENT LP Bought 51.3 Thousand shares of BIOLASE Inc: 9/30/2023: BLACKROCK FUND ADVISORS Bought 23.8 Thousand shares of BIOLASE Inc: 9/30/2023: ZHANG FINANCIAL LLC ...9/30/2023: ANSON FUNDS MANAGEMENT LP Bought 51.3 Thousand shares of BIOLASE Inc: 9/30/2023: BLACKROCK FUND ADVISORS Bought 23.8 Thousand shares of BIOLASE Inc: 9/30/2023: ZHANG FINANCIAL LLC ...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Nov 7, 2023 · LAKE FOREST, Calif., Nov. 7, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and ... Feb 28, 2019 · BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. LAKE FOREST, Calif., Oct. 27, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2022 financial and operating results on Thursday, November 10, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m ...biolase careers Join Us in Advancing Dentistry Search Open Positions BIOLASE Named 2022 TOP WORKPLACE BIOLASE was recognized as a Top Workplace in 2022 by both the Orange County Register and the Inland News Group. The award was based on feedback collected through an employee survey administered by Energage LLC in July and August …

IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriters have agreed to purchase, on a firm commitment basis, 14,000,000 shares of common stock of the …BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2022, and to answer questions. To access the live call, dial 1-877-545-0320 (U.S.) or +1 973-528-0002 (International) and provide the following code: 838343.BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.Instagram:https://instagram. who insures jewelrybest vanguard bond funds for 2023blockchain technology companiespff ex dividend date Nov 20, 2023 · BIOLASE Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. BIOLASE Inc’s trailing 12-month revenue is $49.7 million with a -50.6% profit margin. Year-over-year quarterly sales growth most recently was -9.2%. Analysts expect adjusted earnings to reach $-26.145 per share for the current fiscal year. best forex brokers that accept us clientsrhidium price When it comes to staying informed and up-to-date with the latest news, there are countless options available. One popular choice for many people is Apple News, a news aggregator developed by Apple Inc. should i buy amc stock BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR. BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON …LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public ...BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is 800 …